the role of pacritinib in managing thrombocytopenia in patients with myelofibrosis
Published 1 year ago • 81 plays • Length 0:46Download video MP4
Download video MP3
Similar videos
-
1:17
the use of pacritinib in thrombocytopenic patients with myelofibrosis undergoing allosct
-
1:24
the promising role of pacritinib for the treatment of patients with mf and severe thrombocytopenia
-
1:46
the efficacy of pacritinib in patients with myelofibrosis who have both thrombocytopenia and anemia
-
2:28
investigating the impact of pacritinib on survival in patients with mf and severe thrombocytopenia
-
1:45
design and results of pacritinib for myelofibrosis trial (persist-1)
-
3:48
efficacy of momelotinib in thrombocytopenic patients with myelofibrosis from momentum
-
16:39
diagnosis and management of pnh in 2017
-
5:21
what is prothrombin time?
-
2:04
design and results of persist-1 trial of pacritinib for myelofibrosis
-
3:37
an overview of platelet dysfunction in patients with myeloproliferative neoplasms
-
3:46
results of the phase iii persist-1 trial of pacritinib for myelofibrosis
-
3:56
results of the phase ii titan study of caplacizumab in patients with attp
-
1:23
the challenge of relapse in transplant-eligible & transplant-ineligible patients with bdpcn
-
1:06
pirtobrutinib in r/r mzl: insights from the bruin trial
-
1:19
phase i trial of plamotamab in r/r nhl
-
1:28
phase i study of pevonedistat and ibrutinib in r/r b-nhl
-
1:19
fedratibib improves hrqol in myelofribrosis
-
1:35
update on phase i study of plamotamab in r/r nhl
-
1:24
phase i study of plamotamab in r/r nhl
-
1:35
long-term follow-up from the oiti trial: ponatinib in patients with cml in italy
-
1:35
outcomes of allosct following blinatumomab in children and young adults with r/r b-all
-
2:25
results from a phase i/ii trial of pirtobrutinib and lv20.19 for patients with r/r lymphomas